CHRISTA BLEYLEBEN          

Christa brings more than 25 years of experience in building global relationships – working in executive management roles in both the public and private sector

  • Executive Director, Massachusetts Office of International Trade & Investment, managing teams in Boston, China, Europe and Latin America

  • Oversaw 50 projects from 19 countries, leading to investment flows exceeding $200MM

  • Led E.U. sponsored tech transfer project (6 E.U. regions+MA/40 Bio companies/200 meetings)

  • Initiated formal collaborations to promote life science partnerships with regions/countries including Lombardy; Chile; Life Science Corridor, France; Haifa, Israel; China & others

  • Established Massachusetts Technology Center in China’s largest Hi-Tech park, supporting university, public and private sector collaborations between China and Massachusetts

  • Managing Director/Group Head at Banc of America Securities and predecessor institutions

  • Board of German American Business Council, immediate past Chair of Eastern Trade Council

ROBERT GOTTLIEB                     

Robert has more than 30 years of experience in the biotech and pharma industries in strategy and communications

          Co-founder, Feinstein Kean Healthcare consultancy.  Advised >100 start ups to multi-nationals in positioning, preparation for financing, and partnering, and science communications

          Advisor, Massachusetts Biotechnology Council

          Biogen Communications Director

          FDC Reports, “The Pink Sheet” Executive Editor

NANCY J. LEVY Ph.D.                            

Nancy brings more than 20 years experience in commercial strategy, business development and financing for life science companies

       CEO and President of biomedical company in Cambridge, MA biomedical company; brought in 3 rounds of financing

       Successfully brought products to market at multiple companies including Genzyme, Millennium and Immunetics

       Raised significant amounts of financing for clients from venture capitalists, angels and grants

       Regularly invited speaker at international congresses on how to bring innovation to market

MARK TRUSHEIM                              

Mark brings more than 25 years of experience as a senior biotech company executive, industry leader, and consultant in public policy, corporate development and financing

          Founding President and CEO Cantata Labs, a clinical diagnostics/biomarker startup

          Co-President, COO of Cereon Genomics (Millennium/Monsanto venture);

          10-year career at Monsanto/Pharmacia

          Former Board Member and interim President, Massachusetts Biotechnology Council

          Executive in Residence/Visiting Scientist, MIT Sloan School

          Special Government Employee for FDA Office of the Commissioner